Achieve life sciences announces participation at ld micro invitational conference

Seattle and vancouver, british columbia, may 26, 2022 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the ld micro invitational conference. the conference is taking place in-person at the four seasons in westlake village, ca from june 7 - 9, 2022. details to access the presentation are as follows:
ACHV Ratings Summary
ACHV Quant Ranking